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Abstract:
Background: PHPT is the third most common endocrine disease, but it remains often
overlooked and underdiagnosed. Several strategies, including biochemical markers used
alone or combined in complex algorithms, have been investigated in the past with the aim to
identify tools useful to easily diagnose or screen PHPT. At present, however, the diagnosis of
PHPT remains challenging, especially in asymptomatic patients. As serum calcium (Ca) and
phosphorous (P) are inversely related in PHPT, the Ca/P ratio might be considered a good
candidate tool in the diagnosis of PHPT. Surprisingly, no data on Ca/P ratio are available in
literature, despite they are very simple biochemical measurements largely available in any
clinical laboratory setting. The aim of this study is to investigate the diagnostic value of the
Ca/P ratio in the diagnosis of PHPT. Material and Methods: Data retrospectively obtained
from review charts of 97 patients with documented PHPT (69 females; 28 males) were
compared with those of 96 controls (C) (44 females; 52 males). Exclusion criteria: age <18yrs,
severe chronic diseases, cancer, bone metabolic diseases, use of medications affecting
serum Ca. Biochemical measurements included PTH, Vitamin D (LIASON, XL, Diasorin
device), serum Ca, P, albumin, and creatinine (AU 680 Beckman device). Normal ranges were
15-88 pg/mL, 8.5-11, and 2.5-5.1 mg/dl for PTH, Ca, and P, respectively. SPSS 19.0 and
SigmaPlot 11.0 were used for statistical analyses for group comparisons, ROC curves and
cutoffs performance. Results: Among PHPT patients, 16 (17%) had severe hypercalcemia
(>12 mg/dL), 44 (45%) mild hypercalcemia, and 36 (38%) normocalcemic PHPT (NCHPT). Ca
was significantly higher in PHPT (median: 11; min-max: 9.4-15.5) than C (9.4;8.3-10.2)
(p<0.0001). P was significantly lower in PHPT (2.4;1.4-3.9) than in C (3.5;2.1-4.5) (p<0.0001).
PTH was significantly higher in PHPT (135.2;57.6-1748) than in C (32.1;14-106.1) (p<0.0001).
Ca/P ratio was significantly higher in PHPT than in C. ROC curves analyses identified a cutoff
of 3.5 for both Ca/P ratio and Ca/P ratio obtained by using Ca corrected by albumin. The
sensitivity and specificity were 86% and 87%, respectively for Ca/P ratio and 89% and 93%,
respectively for corrected Ca/P ratio (p<0.0001).The diagnostic value of Ca/P ratio was
significantly better if compared with PTH and Ca used alone or in combination. Conclusions:
Ca/P ratio is a valuable highly sensitive, highly specific tool for the diagnosis of PHPT.
Considering that Ca/P is simple to obtain, easily accessible in every clinical and laboratory
setting worldwide, and inexpensive even when used in large sample size of patients, this
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diagnostic tool could be useful for screening PHPT, especially in patients accessing
emergency rooms or in the general practitioner setting.
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Abstract:
Background: PHPT is the third most common endocrine disease, but it remains often
overlooked and underdiagnosed. Several strategies, including biochemical markers used
alone or combined in complex algorithms, have been investigated in the past with the aim to
identify tools useful to easily diagnose or screen PHPT. At present, however, the diagnosis of
PHPT remains challenging, especially in asymptomatic patients. As serum calcium (Ca) and
phosphorous (P) are inversely related in PHPT, the Ca/P ratio might be considered a good
candidate tool in the diagnosis of PHPT. Surprisingly, no data on Ca/P ratio are available in
literature, despite they are very simple biochemical measurements largely available in any
clinical laboratory setting. The aim of this study is to investigate the diagnostic value of the
Ca/P ratio in the diagnosis of PHPT. Material and Methods: Data retrospectively obtained
from review charts of 97 patients with documented PHPT (69 females; 28 males) were
compared with those of 96 controls (C) (44 females; 52 males). Exclusion criteria: age <18yrs,
severe chronic diseases, cancer, bone metabolic diseases, use of medications affecting
serum Ca. Biochemical measurements included PTH, Vitamin D (LIASON, XL, Diasorin
device), serum Ca, P, albumin, and creatinine (AU 680 Beckman device). Normal ranges were
15-88 pg/mL, 8.5-11, and 2.5-5.1 mg/dl for PTH, Ca, and P, respectively. SPSS 19.0 and
SigmaPlot 11.0 were used for statistical analyses for group comparisons, ROC curves and
cutoffs performance. Results: Among PHPT patients, 16 (17%) had severe hypercalcemia
(>12 mg/dL), 44 (45%) mild hypercalcemia, and 36 (38%) normocalcemic PHPT (NCHPT). Ca
was significantly higher in PHPT (median: 11; min-max: 9.4-15.5) than C (9.4;8.3-10.2)
(p<0.0001). P was significantly lower in PHPT (2.4;1.4-3.9) than in C (3.5;2.1-4.5) (p<0.0001).
PTH was significantly higher in PHPT (135.2;57.6-1748) than in C (32.1;14-106.1) (p<0.0001).
Ca/P ratio was significantly higher in PHPT than in C. ROC curves analyses identified a cutoff
of 3.5 for both Ca/P ratio and Ca/P ratio obtained by using Ca corrected by albumin. The
sensitivity and specificity were 86% and 87%, respectively for Ca/P ratio and 89% and 93%,
respectively for corrected Ca/P ratio (p<0.0001).The diagnostic value of Ca/P ratio was
significantly better if compared with PTH and Ca used alone or in combination. Conclusions:
Ca/P ratio is a valuable highly sensitive, highly specific tool for the diagnosis of PHPT.
Considering that Ca/P is simple to obtain, easily accessible in every clinical and laboratory
setting worldwide, and inexpensive even when used in large sample size of patients, this
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diagnostic tool could be useful for screening PHPT, especially in patients accessing
emergency rooms or in the general practitioner setting.
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